Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma. [electronic resource]
Producer: 20180823Description: 1841-1849 p. digitalISSN:- 1432-0584
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Area Under Curve
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Fibrinogen -- analysis
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- blood
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Prognosis
- Proportional Hazards Models
- ROC Curve
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Rituximab -- administration & dosage
- Severity of Illness Index
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.